Precision Optics (POCI) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
24 May, 2026Strategic focus and business model
Vertically integrated optics company leveraging proprietary micro-optics and imaging technologies for healthcare and defense/aerospace sectors, offering services from concept to mass manufacture.
Engages early with key medical device and defense clients, providing expertise in micro-optics, 3D, and digital imaging.
Maintains a robust pipeline for future commercial production, supported by ongoing R&D and intellectual property updates.
Differentiated by micro-optics, 3D imaging, and digital imaging capabilities, with over 25 years of technical experience.
Product and technology highlights
Offers millimeter-sized cameras and imaging systems enabling new and minimally invasive surgical procedures.
Designs and manufactures 3D endoscopes for robotic and minimally invasive surgery, with applications in 4K, fluorescence, and AR/VR systems.
Develops digital imaging electronics, including CMOS-based systems and LED illumination, supporting both single-use and reusable devices.
Unity Platform accelerates endoscopic device development, reducing costs and time to market through modular, customizable systems.
Key markets and recent orders
Serves medical device markets such as neurosurgery, ophthalmology, urology, and robotic surgery, with single-use endoscopes growing at 15–20% CAGR.
Expanding presence in defense/aerospace, focusing on satellite communications, UAVs, directed energy weapons, and laser communications.
Secured a $9 million single-use cystoscopy order (May 2024) and a top-tier aerospace program with $4 million annual commitments through 2026.
Latest events from Precision Optics
- Revenue and margins surged as new satellite and medical device programs fueled rapid growth.POCI
Lytham Partners Fall 2026 Investor Conference - Record revenue and profitability gains in FY2026 driven by space and medical device growth.POCI
Investor presentation - Record revenue and margin gains, but FY 2027 outlook impacted by satellite order slowdown.POCI
Q4 2026 - Growth accelerates as micro-optics drive expansion in satellite, defense, and single-use endoscopy.POCI
Lytham Partners 2026 Consumer & Technology Investor Summit - Production ramp in medical and satellite optics drives revenue growth and margin recovery.POCI
Planet MicroCap Las Vegas 2026 - Accelerated revenue growth driven by new production programs and robust technology pipeline.POCI
Lytham Partners Spring 2026 Investor Conference - Record Q3 revenue, margin gains, and a $10M+ offering drove raised FY2026 guidance.POCI
Q3 2026 - Strong revenue growth and major orders fuel expansion in medical and defense optics.POCI
Investor presentation - Revenue and margins fell, but backlog and new contracts support a strong Q4 outlook.POCI
Q3 2025